Molecular diagnostics point of care (POC) refers to the use of molecular testing methods and technologies to rapidly diagnose diseases or conditions at or near the patient's location, rather than sending samples to a centralized laboratory for analysis. • It involves the detection and analysis of specific molecules, such as nucleic acids (DNA or RNA), proteins, or other biomarkers, that are indicative of a particular disease or condition.

Biometric POS terminals comprise point-of-sale (POS) devices that use biometrics-based data like fingerprints, retina scans, or even facial recognition to authenticate the identity of a customer or employee. These terminals replace PINs or passwords to verify the identity of the individual. Biometric POS terminals are often used to prevent fraud and theft or in key industries where security is critical. The retail, medical and healthcare, food service (restaurants), financial, logistics, government, and entertainment industries are some of the major end-users of biometric POS terminals.

The global bioanalytical testing services market is estimated to grow at a CAGR of 10.2% from 2022 to 2030. Key factors driving the market growth are increasing outsourcing of R&D activities by pharmaceutical companies and high demand for analytical testing of biosimilars and biologics. However, the challenges in development and validation of bioanalytical methods hinders the market growth.

Biosurfactants are known as surface-active compounds that can be synthesized by a selected number of natural and biobased sources. Biosurfactants are popular for their biodegradability and low eco-toxicity. Besides biodegradability, low toxicity & high production potential, biosurfactants have a high surface and interfacial activity. Biosurfactants are commercially produced from natural sources such as vegetable oil, glycerol and glucose by the addition of a non-pathogenic microorganisms. Biosurfactants are extracted from natural sources and are also expected to be an alternative to petrochemicals.

The global bioanalytical testing services market is estimated to grow at a CAGR of 10.2% from 2022 to 2030. Key factors driving the market growth are increasing outsourcing of R&D activities by pharmaceutical companies and high demand for analytical testing of biosimilars and biologics. However, the challenges in development and validation of bioanalytical methods hinders the market growth.